stockrowGenerate Biomedicines, Inc. (GENB) vs Novavax, Inc. (NVAX)
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
- Novavax, Inc. NVAX 10.78 +10.22%
Generate Biomedicines, Inc. and Novavax, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Novavax, Inc. are of similar size ($1.6B and $1.6B). Novavax, Inc. has the higher net margin (−18.6% vs −781.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Novavax, Inc. leads on 12 and Generate Biomedicines, Inc. on 2.
Valuation
Profitability
| Metric | GENB | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 78.01% | 68.51% |
| Operating margin | (751.19%) | (21.23%) | 0.00% |
| Net margin | (781.10%) | (18.64%) | 0.00% |
| Free cash flow margin | (1,692.17%) | (58.05%) | 0.00% |
| Return on equity | 0.00% | 41.08% | (51.96%) |
| Return on assets | (90.35%) | (7.42%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack